Sarah Chapman

Corporate Development & Strategy Lead


Novateur Advisor Since



Therapeutics, Commercialization Strategy, New Product Planning, Pipeline / Portfolio Prioritization, Rare Disease, Oncology, Autoimmune, Cardiometabolic Disease


Business Development, Project Management, Therapeutics

"We support strategic decision-making across the biopharmaceutical development pathway, from pipeline optimization to launch strategy and strategic partnering." 

Sarah Chapman
Corporate Development & Strategy Lead

Sarah has spent her career informing strategic decision-making across the biopharmaceutical industry. Her work has spanned due diligence, partnering and fundraising, drug and franchise strategy, pricing and market access, and overall corporate and business development strategy for biotech and pharmaceutical clients. Her prior experience includes consulting at ClearView Healthcare Partners, where she conducted consulting engagements across most major therapeutic areas. She spent several years researching stem cell behaviour at the Harvard Stem Cell Institute and graduated summa cum laude with her B.A. in Human Developmental and Regenerative Biology from Harvard University

Novateur Newsletter

Subscribe to our newsletter for access to latest updates.

Resource Databases

Access Novateur news as well as FDA and Expert Databases.

Relevant Events

Check out conferences and events we are attending!